Real-time enrollment status for this hematologic malignancy clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 12:05 AM UTC
| NCT Number | NCT06938867 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Malignancy |
| Phase | PHASE1 |
| Target Enrollment | 66 participants |
| Active Locations | 10 sites in the US |
| Sponsor | SNIPR Biome Aps. |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 18, 2026: Clinical trial NCT06938867 is currently recruiting participants. This phase1 study for hematologic malignancy is actively seeking new participants at 10 locations across the United States. The study is sponsored by SNIPR Biome Aps.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06938867 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06938867 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.